Device / Technology News

RSS

Kofax invoice processing solutions reduce costs and improve productivity in health centers

Kofax plc (LSE: KFX), the leading provider of document driven business process automation solutions, today announced it is providing Australia’s largest state public health department with a solution to process approximately 2 million invoices received annually.

5 Jan 2010

GE Healthcare and Intel expand sales and marketing agreement for Intel Health Guide in the U.K.

GE Healthcare, a unit of GE, and Intel Corporation (NASDAQ:INTC) announced today that they have expanded their sales and marketing agreement for the Intel Health Guide to include the United Kingdom. GE Healthcare already markets the Intel Health Guide in the United States.

5 Jan 2010

SBI and ACR publish new recommendations on breast cancer screening

The new recommendations from the Society of Breast Imaging (SBI) and the American College of Radiology (ACR) on breast cancer screening, published in the January issue of the Journal of the American College of Radiology (JACR), state that breast cancer screening should begin at age 40 and earlier in high-risk patients. The recommendations also suggest appropriate utilization of medical imaging modalities such as mammography, magnetic resonance imaging (MRI), and ultrasound for breast cancer screening.

5 Jan 2010

Hospitals to receive payments from Medicare and Medicaid for effective use of EHRs

According to a survey released today by CSC titled “Are Hospitals Ready for Meaningful Use of EHRs?” U.S. hospitals are only halfway to qualifying for government incentive payments aimed at controlling healthcare costs while improving the quality and effective delivery of patient care.

5 Jan 2010

BioPlex 2200 Anti-CCP test for early detection of RA launched

Bio-Rad Laboratories, Inc., a multinational manufacturer and distributor of life science research and clinical diagnostics products, and Axis-Shield plc, an international in-vitro diagnostics (IVD) company, today announced the launch of Bio-Rad's BioPlex® 2200 Anti-CCP test for the early detection of rheumatoid arthritis.

5 Jan 2010

RFA reduces pain in bone metastases patients

Image-guided radiofrequency ablation (RFA), a minimally invasive cancer treatment which can be performed in the outpatient setting, significantly reduced the level of pain experienced by cancer patients with bone (osseous) metastases, limiting the need for strong narcotic pain management, and supporting improved patient frame of mind, according to results of an American College of Radiology Imaging Network (ACRIN) study published online in the journal Cancer.

5 Jan 2010

Three IMOM facilities implement eMix for securely sharing radiology images and reports

Image Movement of Montana (IMOM), a grassroots organization composed of 30 Montana healthcare facilities, announced today that three of its facilities have gone live with eMix after a successful beta test of the groundbreaking new technology. eMix (Electronic Medical Information Exchange) uses cloud computing to securely share radiology images and reports.

5 Jan 2010

Zynx Health lauds definition of “meaningful use” of EHR technology

The U.S. Department of Health and Human Services' Centers for Medicare & Medicare Services (CMS) and the Office of the National Coordinator of Health Information Technology have announced that the definition of “meaningful use” will include the use of evidence-based order sets and clinical decision support at the point of care. This is good news because the peer-reviewed scientific literature has repeatedly shown that clinical decision support and evidence-based order sets can save patient lives and reduce overall healthcare costs.

5 Jan 2010

Significant opportunity for alternative ulcerative colitis biological therapy

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a biological therapy with a mechanism of action other than tumor necrosis factor alpha (TNF-alpha) inhibition for the treatment of moderate to severe ulcerative colitis, would earn a 25 percent patient share according to surveyed U.S. gastroenterologists. Similarly, in Europe, such an agent would also earn 25 percent patient share according to surveyed European gastroenterologists.

5 Jan 2010

ART publishes impressive data on its bioresorbable stent

Arterial Remodeling Technologies (“ART”) announced today that it has disclosed impressive in vivo and in vitro data related to its bioresorbable stent platform—data that validates the Company’s approach to simultaneously balance biocompatibility, biomechanics and bioresorption in a bioresorbable PLA (polylactic acid) stent without altering healing by drug elution from the stent platform.

5 Jan 2010

Exergen TemporalScanner selected as one of 24 "Smartest Products of the Decade"

The Exergen TemporalScanner, a breakthrough innovation in medical thermometry, was selected last week as one of 24 "Smartest Products of the Decade" by Inc. magazine, which stated "These products revolutionized the way we spend our time -- technologically, culturally, and beyond."

5 Jan 2010

New chemoprevention therapy for skin cancer

People with the heritable disorder of the skin called Gorlin syndrome who are genetically predisposed to develop basal cell carcinoma of the skin may have a new chemoprevention therapy on the horizon.

5 Jan 2010

Irvine Scientific receives CE mark for its ART products

Irvine Scientific, a leader in Assisted Reproductive Technologies (ART) announced today that it has received CE mark for a full range of its media designed for ART: Complete P-1® Medium with DSS™, Blastocyst Freeze Media, Blastocyst Thaw Media, Embryo Freeze Media, Embryo Thaw Media, Complete Early Cleavage Medium® (ECM®) with DSS™ and Complete MultiBlast Medium® with DSS™, Sperm Washing Medium, Sperm Maintenance Medium w/ HSA, 7% PVP w/ HSA, 10% PVP w/ HSA.

5 Jan 2010

Boston Scientific commences enrollment in its TAXUS Liberte Stent System study

Boston Scientific Corporation today announced that it has enrolled the first patient in its TAXUS Liberte post-approval study. The study is designed to evaluate real-world clinical outcomes data for the TAXUS® Liberte® Paclitaxel-Eluting Coronary Stent System in combination with a dual antiplatelet therapy drug regimen that includes aspirin and Effient®, a new antiplatelet medication. Co-sponsors of the study include Eli Lilly and Company and Daiichi Sankyo, Inc., manufacturers of Effient, which was recently approved by the U.S. Food and Drug Administration (FDA).

4 Jan 2010

BioElectronics set to market its Allay product in Chinese market

BioElectronics Corporation, the maker of inexpensive, disposable, drug-free, anti-inflammatory devices, today announces its entry into one most dynamic and fastest growing economies in the world, the People's Republic of China.

4 Jan 2010

Cardiogenesis submits an IDE for its PHOENIX System

Cardiogenesis Corporation, today announced that it has submitted an IDE (Investigational Device Exemption) to the Food and Drug Administration to initiate a safety and feasibility trial for its PHOENIX System in patients with refractory angina. The PHOENIX handpiece is the first device specifically designed to allow physician-directed tissue stimulation and injections of biologic or pharmacologic agents to pre-determined areas of myocardium.

4 Jan 2010

Bausch & Lomb launches Crystalens AO intraocular lens

Bausch & Lomb today announced that it is launching the Crystalens® AO, the first aberration-free accommodating intraocular lens (IOL) with aspheric optics to cataract surgeons worldwide.

4 Jan 2010

Cepheid granted EUA for Xpert Flu A Panel test

Cepheid today announced it has been granted Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Xpert® Flu A Panel test.

4 Jan 2010

GeckoSystems to resume in home personal companion robot trials after Holidays

GeckoSystems Intl. Corp. (http://www.geckosystems.com/) announced today that they have resumed their in home personal companion robot trials for elder care after pausing during the Holidays.

4 Jan 2010

Continua Health Alliance to showcase new end-to-end connected health solution at 2010 Consumer Electronics Show

Continua Health Alliance today announced the first end-to-end connected health solution based on the Continua architecture. Continua, the non-profit, open industry alliance of more than 220 leading healthcare and technology organizations, heralded the development as a significant milestone in the group’s mission to establish an ecosystem of interoperable personal connected health solutions.

4 Jan 2010